0120 Deals QTs
BioCentury & Getty Images


Jan. 20 Quick Takes: Beam adds $260M; plus Lilly-Merus, Thermo Fisher-Mesa, Verve, Aclaris, ViGeneron-Daiichi Sankyo  

Jan 21, 2021 | 2:51 AM GMT

Crossover investors supplied Beam Therapeutics Inc. (NASDAQ:BEAM) with $260 million in a private placement early Tuesday, purchasing 2.8 million shares at

Read the full 441 word article

How to gain access

Continue reading with a
two-week free trial.